Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05069415 · ClinicalTrials.gov registry record · NA

Monofocal IOL Visual Outcomes When Targeting Mini Monovision

A NA study of Cataract and Presbyopia, sponsored by Carolina Eyecare Physicians.

Completed
Registry status
NA
Development phase
75
Enrollment target
2
Study locations

NCT05069415 is a NA study of Cataract and Presbyopia that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 75 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05069415, a NA study of Cataract and Presbyopia, has completed, sponsored by Carolina Eyecare Physicians.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
2
Study locations

Study Summary

This study is a 3-month, prospective, up to 2 center, bilateral, randomized subject masked clinical evaluation of a monofocal intraocular lens (IOL) when both eyes are targeted for emmetropia and when the non-dominant eye is targeted for mini monovision (-0.75 D) in patients with or without astigmatism undergoing routine cataract surgery.

Conditions Studied

Interventions

  • DEVICE Eyhance IOL

Study Locations (2)

Florida

  • Center for Sight - Sarasota

South Carolina

  • Carolina Eyecare Physicians, LLC - Mt. Pleasant

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2021-10-04
Est. Completion 2022-11-30
Phase NA

Sponsor

Carolina Eyecare Physicians

11 total trials

What the Registry Record Tells You About NCT05069415

The ClinicalTrials.gov registry entry for NCT05069415 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (67% lower). The listed sponsor is Carolina Eyecare Physicians, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Eyhance IOL is the first listed.

NCT05069415 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, South Carolina.

Frequently Asked Questions

What is clinical trial NCT05069415 about?

NCT05069415 is a clinical study titled "Monofocal IOL Visual Outcomes When Targeting Mini Monovision". This study is a 3-month, prospective, up to 2 center, bilateral, randomized subject masked clinical evaluation of a monofocal intraocular lens (IOL) when both eyes are targeted for emmetropia and when the non-dominant eye is targeted for mini monovision (-0.75 D) in patients with or without astigmat...

What is the current status of trial NCT05069415?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-10-04. Estimated completion is 2022-11-30.

What conditions does trial NCT05069415 study?

This clinical trial studies the following conditions: Cataract, Presbyopia.

What interventions are being tested in trial NCT05069415?

The interventions under investigation include: Eyhance IOL (DEVICE).

Who is sponsoring clinical trial NCT05069415?

This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05069415 being conducted?

This trial has 2 study locations across Florida, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.